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The use of ADHD medicines has increased due to overprescription and trending 
recreational use, especially in adolescents. Repeated exposure to amphetamine psychostimulants 
produces neural and behavioral adaptations that contribute to addictive behavior. Adolescence is a 
time of physical, mental, and emotional development. This study assessed long-term neural 
changes in adulthood, expressed as behavioral cross-sensitization in an open field chamber, 
caused by exposure to amphetamines during adolescence. C57BI/6J mice were treated with low 
doses (0.01, 0.1, or 1 mg/kg) of amphetamines for 10 days during a period of early adolescence 
(P22-P31), followed by a washout period until adulthood (P90) and challenged with a sub-acute 
dose of methamphetamine (METH). Overall results indicate that adolescent animals injected with 
both 1.0 and 0.1mg/kg of amphetamine show increased locomotor activity following a METH 
challenge.  However, activity in the 0.01 mg/kg group was not different from controls, suggesting 
this low dosage does not produce persistent long-term changes in the brain. Our results reflect a 
human model of early teenagers taking prescription amphetamines to treat ADHD, but who do not 
actually have the disorder, are at risk to sensitization to methamphetamine as adults even if they 
are using a very low therapeutic dose. 
 
